DX
DXCM
Year ended Dec 31, 2024 · FY2025 10-K

DexCom (DXCM) 10-K Summary — Year Ended Dec 31, 2024

DexCom filed its annual report, covering financial results and liquidity. The filing references business overview and risk factors sections, but their specific content is not provided in the supplied data.

Key takeaway

Year ended Dec 31, 2024 · FY2025 10-K

DexCom filed its annual report, covering financial results and liquidity. The filing references business overview and risk factors sections, but their specific content is not provided in the supplied data.

Financial snapshot

Selected annual figures reported with the filing, shown separately from the narrative summary.

Annual revenue

$4B

Revenue reported for the fiscal year.

Operating income

$600M

Income from operations reported for the year.

Net income

$576.2M

Net income reported for the year.

Operating cash flow

$989.5M

Cash generated by operating activities.

Annual revenue trend

Reported annual revenue and its change from the preceding fiscal year.

Period endedRevenueYear-over-year change
Dec 31, 2021$2.4Bn/a
Dec 31, 2022$2.9B+18.8%
Dec 31, 2023$3.6B+24.5%
Dec 31, 2024$4B+11.3%

Business overview

The business overview section is listed in the filing, but the actual description is not included in the supplied context. No details about the company’s operations can be extracted from the given data.

Financial performance

Revenue increased over the reported periods, as indicated by the trend data. The company reported positive operating income and net income for the period.

Material risks

The risk factors section is referenced in the filing, but the specific risks are not provided in the supplied context. No material risks can be identified from the available data.

Liquidity and capital

The company’s liquidity is supported by cash, cash equivalents, marketable securities, operating cash flows, convertible notes, and a credit facility. Cash is used for research, sales, marketing, capital expenditures, acquisitions, and debt service.

What to watch

Investors may monitor the company’s revenue growth trend in the next filing, as it has been a key focus in recent periods.